泰格医药(03347.HK) 今日(19日)中午收跌3.19%,报33.42元,创近一年低,成交73.84万股,涉资2,501.11万元。摩根大通发表研究报告指,泰格医药H股股价上周下跌,部分原因为中国证监会对公司联合创始人展开调查,以及首季盈利逊预期。该行认为,调查对公司日常营运影响不大,可能不超过一个月便会结束。报告指出,泰格医药今年首季收入基本符合预期,但盈利表现令人失望。若剔除一次性项目及...
Source Link泰格医药(03347.HK) 今日(19日)中午收跌3.19%,报33.42元,创近一年低,成交73.84万股,涉资2,501.11万元。摩根大通发表研究报告指,泰格医药H股股价上周下跌,部分原因为中国证监会对公司联合创始人展开调查,以及首季盈利逊预期。该行认为,调查对公司日常营运影响不大,可能不超过一个月便会结束。报告指出,泰格医药今年首季收入基本符合预期,但盈利表现令人失望。若剔除一次性项目及...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.